Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population

International Journal of Molecular Sciences

Volumn 15, Issue 11, 2014, Pages 19330-19341

  Zhang, Yu ^a   Sun, Yan ^a   Chen, Tao ^a   Hu, Hailong ^a   Xie, Wanqin ^a   Qiao, Zhihui ^a   Ding, Na ^a   Xie, Linguo ^a   Li, Sheng ^a   Wang, Wenlong ^a   Xing, Chen ^a   Wang, Yihan ^a   Qie, Yunkai ^a   Wu, Changli ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Genetic variations; Genome wide association studies; Polymorphism

Indexed keywords

DNA;

AGED; ARTICLE; BLADDER CANCER; BLOOD ANALYSIS; CANCER STAGING; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; BLADDER TUMOR; CANCER GRADING; CHINA; GENE LOCUS; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MIDDLE AGED; ODDS RATIO; PATHOLOGY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84937598111     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151119330     Document Type: Article

References (36)

1. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
2. Globocan 2012 Home Page. Available online: http://globocan.iarc.fr (accessed on 7 October 2014).
3. Yang, L.; Parkin, D.M.; Li, L.D.; Chen, Y.D.; Bray, F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 2004, 90, 2157-2166.
4. Dudek, A.M.; Grotenhuis, A.J.; Vermeulen, S.H.; Kiemeney, L.A.; Verhaegh, G.W. Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms? Int. J. Mol. Sci. 2013, 14, 12346-12366.
5. Ploeg, M.; Aben, K.K.; Hulsbergen-van de Kaa, C.A.; Schoenberg, M.P.; Witjes, J.A.; Kiemeney, L.A. Clinical epidemiology of nonurothelial bladder cancer: Analysis of The Netherlands cancer registry. J. Urol. 2010, 183, 915-920.
6. Amin, M.B. Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications. Mod. Pathol. 2009, 22, S96-S118.
7. Goebell, P.J.; Knowles, M.A. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol. Oncol. 2010, 28, 409-428.
8. Tang, W.; Fu, Y.P.; Figueroa, J.D.; Malats, N.; Garcia-Closas, M.; Chatterjee, N.; Kogevinas, M.; Baris, D.; Thun, M.; Hall, J.L., et al. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Hum. Mol. Genet. 2012, 21, 1918-1930.
9. Aben, K.K.; Witjes, J.A.; Schoenberg, M.P.; Hulsbergen-van, D.K.C.; Verbeek, A.L.; Kiemeney, L.A. Familial aggregation of urothelial cell carcinoma. Int. J. Cancer 2002, 98, 274-278.
10. Murta-Nascimento, C.; Schmitz-Drager, B.J.; Zeegers, M.P.; Steineck, G.; Kogevinas, M.; Real, F.X.; Malats, N. Epidemiology of urinary bladder cancer: From tumor development to patient’s death. World J. Urol. 2007, 25, 285-295.
11. Aben, K.K.; Baglietto, L.; Baffoe-Bonnie, A.; Coebergh, J.W.; Bailey-Wilson, J.E.; Trink, B.; Verbeek, A.L.; Schoenberg, M.P.; Alfred, W.J.; Kiemeney, L.A., et al. Segregation analysis of urothelial cell carcinoma. Eur. J. Cancer 2006, 42, 1428-1433.
12. Murta-Nascimento, C.; Silverman, D.T.; Kogevinas, M.; Garcia-Closas, M.; Rothman, N.; Tardon, A.; Garcia-Closas, R.; Serra, C.; Carrato, A.; Villanueva, C., et al. Risk of bladder cancer associated with family history of cancer: Do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol. Biomark. Prev. 2007, 16, 1595-1600.
13. Kiemeney, L.A.; Thorlacius, S.; Sulem, P.; Geller, F.; Aben, K.K.; Stacey, S.N.; Gudmundsson, J.; Jakobsdottir, M.; Bergthorsson, J.T.; Sigurdsson, A., et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 2008, 40, 1307-1312.
14. Wu, X.; Ye, Y.; Kiemeney, L.A.; Sulem, P.; Rafnar, T.; Matullo, G.; Seminara, D.; Yoshida, T.; Saeki, N.; Andrew, A.S., et al. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat. Genet. 2009, 41, 991-995.
15. Kiemeney, L.A.; Sulem, P.; Besenbacher, S.; Vermeulen, S.H.; Sigurdsson, A.; Thorleifsson, G.; Gudbjartsson, D.F.; Stacey, S.N.; Gudmundsson, J.; Zanon, C., et al. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat. Genet. 2010, 42, 415-419.
16. Rothman, N.; Garcia-Closas, M.; Chatterjee, N.; Malats, N.; Wu, X.; Figueroa, J.D.; Real, F.X.; van den Berg, D.; Matullo, G.; Baris, D., et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet. 2010, 42, 978-984.
17. Garcia-Closas, M.; Ye, Y.; Rothman, N.; Figueroa, J.D.; Malats, N.; Dinney, C.P.; Chatterjee, N.; Prokunina-Olsson, L.; Wang, Z.; Lin, J., et al. A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3. Hum. Mol. Genet. 2011, 20, 4282-4289.
18. Rafnar, T.; Vermeulen, S.H.; Sulem, P.; Thorleifsson, G.; Aben, K.K.; Witjes, J.A.; Grotenhuis, A.J.; Verhaegh, G.W.; Hulsbergen-van, D.K.C.; Besenbacher, S., et al. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum. Mol. Genet. 2011, 20, 4268-4281.
19. Figueroa, J.D.; Ye, Y.; Siddiq, A.; Garcia-Closas, M.; Chatterjee, N.; Prokunina-Olsson, L.; Cortessis, V.K.; Kooperberg, C.; Cussenot, O.; Benhamou, S., et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum. Mol. Genet. 2014, 23, 1387-1398.
20. Wang, M.; Wang, M.; Zhang, W.; Yuan, L.; Fu, G.; Wei, Q.; Zhang, Z. Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population. Carcinogenesis 2009, 30, 991-996.
21. Wang, S.; Tang, J.; Wang, M.; Yuan, L.; Zhang, Z. Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Carcinogenesis 2010, 31, 621-624.
22. Wang, M.; Chu, H.; Yan, F.; Qin, C.; Li, P.; Yuan, L.; Yin, C.; Xu, J.; Zhang, Z. Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population. Carcinogenesis 2011, 32, 872-875.
23. Ma, Z.; Hu, Q.; Chen, Z.; Tao, S.; Macnamara, L.; Kim, S.T.; Tian, L.; Xu, K.; Ding, Q.; Zheng, S.L., et al. Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population. Mol. Carcinog. 2013, 52, 916-921.
24. Wang, M.; Chu, H.; Lv, Q.; Wang, L.; Yuan, L.; Fu, G.; Tong, N.; Qin, C.; Yin, C.; Zhang, Z., et al. Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer. Int. J. Cancer 2014, 135, 2653-2660.
25. Wang, P.; Ye, D.; Guo, J.; Liu, F.; Jiang, H.; Gong, J.; Gu, C.; Shao, Q.; Sun, J.; Zheng, S.L., et al. Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer. Genes Chromosomes Cancer 2014, 53, 98-105.
26. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62, 10-29.
27. Burger, M.; Catto, J.W.; Dalbagni, G.; Grossman, H.B.; Herr, H.; Karakiewicz, P.; Kassouf, W.; Kiemeney, L.A.; la Vecchia, C.; Shariat, S., et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 2013, 63, 234-241.
28. Rafnar, T.; Sulem, P.; Stacey, S.N.; Geller, F.; Gudmundsson, J.; Sigurdsson, A.; Jakobsdottir, M.; Helgadottir, H.; Thorlacius, S.; Aben, K.K., et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat. Genet. 2009, 41, 221-227.
29. Gu, J.; Wu, X. Genetic susceptibility to bladder cancer risk and outcome. Per Med. 2011, 8, 365-374.
30. Li, C.; Yin, Z.; Wu, W.; Li, X.; Zhou, B. Genetic variants in TERT-CLPTM1L genetic region associated with several types of cancer: A meta-analysis. Gene 2013, 526, 390-399.
31. Tukey, R.H.; Strassburg, C.P. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 581-616.
32. Selinski, S.; Lehmann, M.L.; Blaszkewicz, M.; Ovsiannikov, D.; Moormann, O.; Guballa, C.; Kress, A.; Truss, M.C.; Gerullis, H.; Otto, T., et al. Rs11892031 [A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Arch. Toxicol. 2012, 86, 1369-1378.
33. Yamamoto, K.; Okamoto, A.; Isonishi, S.; Ochiai, K.; Ohtake, Y. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem. Biophys. Res. Commun. 2001, 280, 1148-1154.
34. James, M.A.; Wen, W.; Wang, Y.; Byers, L.A.; Heymach, J.V.; Coombes, K.R.; Girard, L.; Minna, J.; You, M. Functional characterization of CLPTM1L as a lung cancer risk candidate gene in the 5p15.33 locus. PLoS One 2012, 7, e36116.
35. Schoenborn, C.A.; Adams, P.E. Health behaviors of adults: United States, 2005-2007. Vital Health Stat. 2010, 10, 1-132.
36. Cheng, L.; MacLennan, G.T.; Lopez-Beltran, A. Histologic grading of urothelial carcinoma: A reappraisal. Hum. Pathol. 2012, 43, 2097-2108.